Amgen wins patent ruling
From Times Wire Reports
Amgen Inc. of Thousand Oaks won a court ruling blocking Roche Holding from selling the anemia drug Mircera in the U.S. because it infringes Amgen patents.
U.S. District Judge William Young in Boston issued an order repeating his tentative findings from a February hearing.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
